The sodium–glucose co-transporter 2 inhibitor canagliflozin, attenuates cardiac fibrosis and function in inflammatory dilated cardiomyopathy
28 August 2026 (09:15 - 10:00)
Organised by: 
About the speaker
Beijing (China)
7 More presentations in this session
Miss N. Kalf (Amsterdam, NL)
Doctor M. Martini (Padova, IT)
Exercise stress test arrhythmic patterns by genotype in non-desmosomal arrhythmogenic cardiomyopathy
Doctor A. Sularz (Rochester, US)
Miss F. Tuijnenburg (Amsterdam, NL)
Access the full session
The Event
ESC Congress 2026
28 August 2026
09:15 CET
You may be interested in
Congress Presentation
Congress Session
31 August 2024
Congress Presentation
Congress Presentation
